Premium Content Oncology – Journal Spy

Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes

Source: Henriksen JN, et al. Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes. Clinical Genitourinary Cancer, February 2020. DOI: 10.1016/j.clgc.2019.09.013

Please sign in or register for FREE

No comments yet.